Top Markets
#1 Win Win +14.03%
#2 SuperVerse SuperVerse +13.26%
#3 Qkacoin Qkacoin +10.59%
#4 Audiera Audiera +9.27%
#5 Ontology Ontology +8.66%
#6 Testicle Testicle +7.65%
#7 Shuffle Shuffle +6.99%
#8 Hive Hive +5.54%
#9 Naoris Protocol Naoris Protocol +3.52%
#10 TRIA TRIA +3.36%
Coin of the day
Win Win
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Novartis AG Novartis AG

Novartis AG

NVS
Rang in aandelen #47
Novartis AG researches, develops, manufactures, and markets healthcare products... Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.
Aandeelprijs
$150.75
Marktkapitalisatie
$291.41B
Verandering (1 dag)
1.44%
Verandering (1 jaar)
40.17%
Land
CH
Handel Novartis AG (NVS)

Categorie

Healthcare
Dividendgeschiedenis van Novartis AG (NVS)
Novartis AG (aandelsymbool: NVS) heeft in totaal 0 dividenduitkeringen gedaan.
De som van alle dividenden (aangepast voor aandelensplitsingen) is: 0.00
Dividendrendement (TTM): 0
Dividendbetalingen voor Novartis AG (NVS) van 2026 tot 2026
Jaarlijkse dividendbetalingen
Jaar Dividend (aangepast voor aandelensplitsingen) Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Lijst van alle dividendbetalingen
Jaar Dividend Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendbetalingen voor vergelijkbare bedrijven of concurrenten
Bedrijf Aantal dividendbetalingen Land
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
215.00%
US
AstraZeneca PLC AstraZeneca PLC
AstraZeneca PLC
AZN.US
67.00%
GB
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
225.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
53.00%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
223.00%
US